GLP1R and esophageal squamous cell carcinoma: Notably, GLP1R expression appears to have no significant impact on overall survival in cancers such as esophageal squamous cell carcinoma, head-neck squamous cell carcinoma, renal papillary cell carcinoma, liver hepatocellular carcinoma, lung adenocarcinoma, ovarian cancer, and pancreatic cancer.